Trials / Conditions / Primary Peritoneal Undifferentiated Carcinoma
Primary Peritoneal Undifferentiated Carcinoma
5 registered clinical trials studyying Primary Peritoneal Undifferentiated Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With NCT04092270 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cance NCT02364713 | Mayo Clinic | Phase 2 |
| Completed | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance NCT02020707 | Mayo Clinic | Phase 1 |
| Completed | Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epi NCT00951496 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Pa NCT00565851 | National Cancer Institute (NCI) | Phase 3 |